On Invalid Date, Amgen (NASDAQ: AMGN) reported Q3 2023 earnings per share (EPS) of $3.23, up 19.45% year over year. Total Amgen earnings for the quarter were $1.73 billion. In the same quarter last year, Amgen's earnings per share (EPS) was $4.01.
As of Q4 2023, Amgen's earnings has grown 13.02% year over year. This is 2.43 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 10.59%. Amgen's earnings in the past year totalled $7.57 billion.
What is AMGN's earnings date?
Amgen's earnings date is Invalid Date. Add AMGN to your watchlist to be reminded of AMGN's next earnings announcement.
What was AMGN's revenue last quarter?
On Invalid Date, Amgen (NASDAQ: AMGN) reported Q3 2023 revenue of $6.90 billion up 3.77% year over year. In the same quarter last year, Amgen's revenue was $6.65 billion.
What was AMGN's revenue growth in the past year?
As of Q4 2023, Amgen's revenue has grown 1.91% year over year. This is 0.63 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 1.28%. Amgen's revenue in the past year totalled $26.83 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.